SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001306923-20-000010
Filing Date
2020-02-14
Accepted
2020-02-14 14:59:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 Epizyme_13G_A5.txt SC 13G/A 9992
2 Epizyme_13G_A5.pdf SC 13G/A 62223
  Complete submission text file 0001306923-20-000010.txt   97414
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

IRS No.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87481 | Film No.: 20618408
SIC: 2834 Pharmaceutical Preparations